These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16006589)

  • 1. Prostacyclin signaling in the kidney: implications for health and disease.
    Nasrallah R; Hébert RL
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F235-46. PubMed ID: 16006589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandins in the kidney: developments since Y2K.
    Nasrallah R; Clark J; Hébert RL
    Clin Sci (Lond); 2007 Oct; 113(7):297-311. PubMed ID: 17760567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathway of prostacyclin signaling-hanging out with nuclear receptors.
    Lim H; Dey SK
    Endocrinology; 2002 Sep; 143(9):3207-10. PubMed ID: 12193530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis.
    Pulichino AM; Rowland S; Wu T; Clark P; Xu D; Mathieu MC; Riendeau D; Audoly LP
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1043-50. PubMed ID: 16973887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple signalling options for prostacyclin.
    Wise H
    Acta Pharmacol Sin; 2003 Jul; 24(7):625-30. PubMed ID: 12852825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of prostacyclin on adriamycin-induced apoptosis in rat renal tubular cells.
    Chen CH; Lin H; Hsu YH; Sue YM; Cheng TH; Chan P; Chen TH
    Eur J Pharmacol; 2006 Jan; 529(1-3):8-15. PubMed ID: 16343480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
    Józefowski S; Bobek M; Marcinkiewicz J
    Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor alpha plays a crucial role in L-carnitine anti-apoptosis effect in renal tubular cells.
    Chen HH; Sue YM; Chen CH; Hsu YH; Hou CC; Cheng CY; Lin SL; Tsai WL; Chen TW; Chen TH
    Nephrol Dial Transplant; 2009 Oct; 24(10):3042-9. PubMed ID: 19491382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells.
    Cutler NS; Graves-Deal R; LaFleur BJ; Gao Z; Boman BM; Whitehead RH; Terry E; Morrow JD; Coffey RJ
    Cancer Res; 2003 Apr; 63(8):1748-51. PubMed ID: 12702555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartmentalization of prostaglandins and prostacyclin within the kidney: implications for renal function.
    McGiff JC; Wong PY
    Fed Proc; 1979 Jan; 38(1):89-93. PubMed ID: 103756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis.
    Honda T; Segi-Nishida E; Miyachi Y; Narumiya S
    J Exp Med; 2006 Feb; 203(2):325-35. PubMed ID: 16446378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.
    Chen HH; Chen TW; Lin H
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1109-18. PubMed ID: 19640904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice.
    Yu Y; Stubbe J; Ibrahim S; Song WL; Smyth EM; Funk CD; FitzGerald GA
    Circ Res; 2010 Feb; 106(2):337-45. PubMed ID: 19940265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin D2 pathway and peroxisome proliferator-activated receptor gamma-1 expression are induced by mechanical loading in an osteoblastic cell line.
    Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
    J Periodontal Res; 2006 Apr; 41(2):92-100. PubMed ID: 16499711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and inflammation: the cyclooxygenase controversy.
    Morteau O
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):473-80. PubMed ID: 11197601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice.
    Popp L; Häussler A; Olliges A; Nüsing R; Narumiya S; Geisslinger G; Tegeder I
    Eur J Pain; 2009 Aug; 13(7):691-703. PubMed ID: 18938093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins and the regulation of tumor growth.
    Bishop-Bailey D; Calatayud S; Warner TD; Hla T; Mitchell JA
    J Environ Pathol Toxicol Oncol; 2002; 21(2):93-101. PubMed ID: 12086407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues.
    Needleman P; Bronson SD; Wyche A; Sivakoff M; Nicolaou KC
    J Clin Invest; 1978 Mar; 61(3):839-49. PubMed ID: 346605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostanoids and prostanoid receptors in signal transduction.
    Bos CL; Richel DJ; Ritsema T; Peppelenbosch MP; Versteeg HH
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1187-205. PubMed ID: 15109566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of cyclooxygenase-2 and prostacyclin/IP receptors in mucosal defense against ischemia/reperfusion injury in mouse stomach.
    Kotani T; Kobata A; Nakamura E; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2006 Feb; 316(2):547-55. PubMed ID: 16236816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.